Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results

BACKGROUND: This study investigated the effects of oral dimercapto succinic acid (DMSA) therapy on the behavioural symptoms of children with autism spectrum disorders (ASD) ages 3-8 years. METHODS: Phase 1 involved 65 children with ASD who received one round of DMSA (3 days). Participants who had hi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Adams, James B, Baral, Matthew, Geis, Elizabeth, Mitchell, Jessica, Ingram, Julie, Hensley, Andrea, Zappia, Irene, Newmark, Sanford, Gehn, Eva, Rubin, Robert A, Mitchell, Ken, Bradstreet, Jeff, El-Dahr, Jane
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2009
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2770991/
https://ncbi.nlm.nih.gov/pubmed/19852790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-9-17
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller